NMRA – neumora therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Guggenheim. They now have a $14.00 price target on the stock.
Neumora Therapeutics (NMRA) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
Neumora Therapeutics Inc (NMRA) Q4 2025 Earnings Call Highlights: Strong Financial Position ... [Yahoo! Finance]
Form DEFA14A Neumora Therapeutics,
Form DEF 14A Neumora Therapeutics, For: May 27
Form SCHEDULE 13D/A Neumora Therapeutics, Filed by: ARCH Venture Fund XII, L.P.
Form S-8 Neumora Therapeutics,
Form 10-K Neumora Therapeutics, For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.